BIO-key International (NASDAQ:BKYI – Get Free Report) was upgraded by analysts at Zacks Research to a “hold” rating in a note issued to investors on Thursday,Zacks.com reports.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, BIO-key International currently has a consensus rating of “Reduce”.
Get Our Latest Analysis on BKYI
BIO-key International Price Performance
Institutional Investors Weigh In On BIO-key International
A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC raised its position in BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 as of its most recent filing with the SEC. 26.51% of the stock is owned by hedge funds and other institutional investors.
BIO-key International Company Profile
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
See Also
- Five stocks we like better than BIO-key International
- MarketBeat Week in Review – 08/03 – 08/07
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
